✦ LIBER ✦

Activity of Lenalidomide in Patients with Relapsed or Refractory Multiple Myeloma: Data from Phase III Studies

✍ Scribed by Gibson, Tara Beers; Mariani, Sara; Jain, Vinay K.

Book ID: 118629193
Publisher: CIG Media Group, LP.
Year: 2005
Tongue: English
Weight: 849 KB
Volume: 6
Category: Article
ISSN: 1557-9190
DOI: 10.1016/s1557-9190(11)70373-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of temsirolimus in patien

Phase II trial of temsirolimus in patients with relapsed or refractory multiple myeloma

✍ Sherif S. Farag; Shuhong Zhang; Buffy S. Jansak; Xiaojing Wang; Eric Kraut; Kenn 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 508 KB

In a phase II trial, 16 patients with relapsed refractory multiple myeloma received temsirolimus 25mg I.V. weekly until progression. One partial response and 5 minor responses were observed for a total response rate of 38%. The median time to progression was 138 days. Grade 3-4 toxicity included fat

Phase 2 study of arsenic trioxide in pat

Phase 2 study of arsenic trioxide in patients with relapsed or refractory multiple myeloma

✍ Mohamad A. Hussein; Mansoor Saleh; Farhad Ravandi; James Mason; Robert M. Rifkin 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

A114 Effectiveness of Lenalidomide in Pa

A114 Effectiveness of Lenalidomide in Patients with Relapsed or Progressive Multiple Myeloma

✍ Amor, AA; Casanova, M; Fuertes, M; Guzmán, JL; Bueno, BA; Giraldo, P; Cánovas, A 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 110 KB

Lenalidomide in combination with dexamet

Lenalidomide in combination with dexamethasone: effective regimen in patients with relapsed or refractory multiple myeloma complicated by renal impairment

✍ Ulrike Klein; Kai Neben; Thomas Hielscher; Christiane Heiß; Anthony D. Ho; Hartm 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 204 KB

The efficacy and safety of lenalidomide

The efficacy and safety of lenalidomide plus dexamethasone in relapsed and/or refractory multiple myeloma patients with impaired renal function

✍ Meletios Dimopoulos; Adrian Alegre; Edward A. Stadtmauer; Hartmut Goldschmidt; J 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 1 views

Long-term follow-up on overall survival

Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma

✍ Dimopoulos, M A; Chen, C; Spencer, A; Niesvizky, R; Attal, M; Stadtmauer, E A; P 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 164 KB